Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07255209 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of IBI362 in Chinese Adolescents With Obesity or Overweight

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 1, 2025 to Dec 29, 2025 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Dec 1, 2025 to Dec 29, 2025
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is designed to assess the efficacy and safety of multiple doses of IBI362 in Chinese adolescent subjects with obesity or overweight. It plans to enroll 180 adolescents (aged ≥12 and \<18 years) who have failed to achieve a 5 kg weight reduction after at least 12 weeks of dietary and exercise intervention.
Trial Details
NCT Number NCT07255209
Lead Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Conditions Adolescents With Obesity or Overweight With Weight-Related Comorbidities
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov